Tamoxifen Citrate

ACTIVE HALF-LIFE 5-7 Days
CLASSIFICATION SERM
DOSAGE 20 mg/day
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Hilma Biocare
LAB TEST See Document
WAREHOUSE EU Warehouse 3
SUBSTANCE Tamoxifen Citrate ,

Tamoxifen exhibits a broad range of pharmacological effects, acting as both an estrogen antagonist and agonist in different tissues. Developed in 1961 by ICI (AstraZeneca), Tamoxifen Citrate has demonstrated remarkable efficacy in treating breast cancer and alleviating estrogen-related side effects associated with anabolic steroid use. This medication is also effective for treating other cancers, such as ovarian, endometrial, prostate, and kidney cancers, as well as conditions like melanoma and soft tissue sarcomas, provided the tumors express estrogen receptors. Tamoxifen Citrate belongs to the Selective Estrogen Receptor Modulator (SERM) class and is commonly utilized by bodybuilders during post-cycle therapy (PCT).

Tamoxifen Citrate is very effective during PCT. It aids athletes in restoring normal testosterone levels and reviving libido, which may have been diminished by the use of other steroids.

Common side effects associated with Tamoxifen Citrate include headaches, insomnia, nausea, digestive issues, fatigue, and leg cramps.

Tamoxifen Citrate can be effectively combined with clomiphene during PCT.